Eli Lilly’s multi-dose prefilled pen for telportin injection is launched in China
June 16, 2025
Source: drugdu
105
June 12th, Eli Lilly announced that Mufengda (multi-dose prefilled pen for tilpotide injection) is available in China. This is a new injection device launched by Eli Lilly after the successful launch of tilpotide at the beginning of the year . Tilpotide injection is the world's first and currently the only once-weekly glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonist approved for T2DM and long-term weight management. The launch of the multi-dose prefilled pen is to increase supply in China and meet the needs of more patients.
网址：https://finance.eastmoney.com/a/202506123428962957.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- the first of its kind to achieve the primary endpoint of mid-term analysis in nasopharyngeal carcinoma stage III clinical trials with iza bene July 4, 2025
- Gout treatment welcomes new choices! Changchun High tech’s first domestically approved injection of Fuxinqibai monoclonal antibody for market launch July 4, 2025
- this is the path to carbon neutrality July 4, 2025
- Dizal (Jiangsu) Pharmaceutical Co., Ltd. Voluntary Disclosure of Announcement Regarding Accelerated Marketing Approval of Suvoderm® by the U.S. FDA July 4, 2025
- Rare, Recurrent, and Still a Challenge July 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
